How the Biggest and Best Funds Fared After the Crash
A look at how some notable U.S. equity funds have navigated the market's style and size reversals over the past year.
It's been quite a turnaround for U.S. stocks and the funds that own them since the market's March 23, 2020, bottom. The coronavirus pandemic sell-off, in which the Morningstar US Market Extended Index fell 35% in only 23 trading days, gave way to a rapid recovery and even higher market peaks. In the year since the bottom, the benchmark gained more than 85%.
Not every corner of the market took the same path upward. Although growth stocks, especially large caps, held up relatively well in the crash and then benefited from lockdowns and ultralow interest rates, the small-value Morningstar Category has outperformed since Pfizer (PFE) and BioNTech (BNTX) announced successful COVID-19 vaccine results on Monday, Nov. 9, 2020.
Alec Lucas has a position in the following securities mentioned above: AOFAX, PFE, AMRMX, DODGX, OAKLX. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.